Combatting sexually transmitted infections (STIs) and dismantling societal taboos.
STIs are a hidden global epidemic, with more than 400 M new cases every year.1
Most infections are asymptomatic, meaning that they are often unnoticed and left untreated. But STIs infections can have devastating consequences, especially for women, including cervical cancer and infertility.
Despite health organisations recommend chlamydia screening at least once per year,2 embarrassment and inconvenience often deter people from getting tested.
1 World Health Organization
2 Centers for Disease Control and Prevention
Radetec is developing a new type of STI rapid test that could conveniently be sold in pharmacies and use it privately at home.
Radetec enjoys significant competitive advantages which can be summarised below:
Home-based, self-testing. Eliminates reluctance to take tests due to fear of embarrassment.
The kit allows for much lower costs compared to traditional testing options.
Results available after 10 minutes of sample application.
Easy swab-based test with minimal intrusion.
How it Works
Radetec's platformtechnology combines validated molecular and serological assays with fluorescent "quantum dots" nanoparticles and lateral flow devices.
Our rapid tests have near PCR sensitivity, portability and easiness of use.